-
1
-
-
0030018209
-
Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor
-
Vlodavsky I, Miao HQ, Medalion B, Danagher P, Ron D Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Metastasis Rev 1996, 15:177-186.
-
(1996)
Cancer Metastasis Rev
, vol.15
, pp. 177-186
-
-
Vlodavsky, I.1
Miao, H.Q.2
Medalion, B.3
Danagher, P.4
Ron, D.5
-
2
-
-
48549085133
-
Heparanase: one molecule with multiple functions in cancer progression
-
Vlodavsky I, Elkin M, Abboud-Jarrous G, Levi-Adam F, Fuks L, Shafat I, Ilan N Heparanase: one molecule with multiple functions in cancer progression. Connect Tissue Res 2008, 49:207-210.
-
(2008)
Connect Tissue Res
, vol.49
, pp. 207-210
-
-
Vlodavsky, I.1
Elkin, M.2
Abboud-Jarrous, G.3
Levi-Adam, F.4
Fuks, L.5
Shafat, I.6
Ilan, N.7
-
3
-
-
85027930332
-
Rethinking the metastatic cascade as a therapeutic target
-
Mina LA, Sledge GW Rethinking the metastatic cascade as a therapeutic target. Nat Rev Clin Oncol 2011, 8:325-332.
-
(2011)
Nat Rev Clin Oncol
, vol.8
, pp. 325-332
-
-
Mina, L.A.1
Sledge, G.W.2
-
4
-
-
0032563303
-
Substrate specificity of heparanases from human hepatoma and platelets
-
Pikas DS, Li JP, Vlodavsky I, Lindahl U Substrate specificity of heparanases from human hepatoma and platelets. J Biol Chem 1998, 273:18770-18777.
-
(1998)
J Biol Chem
, vol.273
, pp. 18770-18777
-
-
Pikas, D.S.1
Li, J.P.2
Vlodavsky, I.3
Lindahl, U.4
-
5
-
-
0037044815
-
Structural recognition by recombinant human heparanase that plays critical roles in tumor metastasis. Hierarchical sulfate groups with different effects and the essential target disulfated trisaccharide sequence
-
Okada Y, Yamada S, Toyoshima M, Dong J, Nakajima M, Sugahara K Structural recognition by recombinant human heparanase that plays critical roles in tumor metastasis. Hierarchical sulfate groups with different effects and the essential target disulfated trisaccharide sequence. J Biol Chem 2002, 277:42488-42495.
-
(2002)
J Biol Chem
, vol.277
, pp. 42488-42495
-
-
Okada, Y.1
Yamada, S.2
Toyoshima, M.3
Dong, J.4
Nakajima, M.5
Sugahara, K.6
-
6
-
-
83255163230
-
Computational analyses of the catalytic and heparin-binding sites and their interactions with glycosaminoglycans in glycoside hydrolase family 79 endo-β-d-glucuronidase (heparanase)
-
Gandhi NS, Freeman C, Parish CR, Mancera RL Computational analyses of the catalytic and heparin-binding sites and their interactions with glycosaminoglycans in glycoside hydrolase family 79 endo-β-d-glucuronidase (heparanase). Glycobiology 2012, 22:35-55.
-
(2012)
Glycobiology
, vol.22
, pp. 35-55
-
-
Gandhi, N.S.1
Freeman, C.2
Parish, C.R.3
Mancera, R.L.4
-
7
-
-
77952002191
-
Unraveling the specificity of heparanase utilizing synthetic substrates
-
Peterson SB, Liu J Unraveling the specificity of heparanase utilizing synthetic substrates. J Biol Chem 2010, 285:14504-14513.
-
(2010)
J Biol Chem
, vol.285
, pp. 14504-14513
-
-
Peterson, S.B.1
Liu, J.2
-
8
-
-
34247637147
-
Heparanase: a target for drug discovery in cancer and inflammation
-
McKenzie EA Heparanase: a target for drug discovery in cancer and inflammation. Br J Pharmacol 2007, 151:1-14.
-
(2007)
Br J Pharmacol
, vol.151
, pp. 1-14
-
-
McKenzie, E.A.1
-
9
-
-
2442618965
-
2,3-Dihydro-1,3-dioxo-1H-isoindole-5-carboxylic acid derivatives: a novel class of small molecule heparanase inhibitors
-
Courtney SM, Hay PA, Buck RT, Colville CS, Porter DW, Scopes DI, Pollard FC, Page MJ, Bennett JM, Hircock ML, McKenzie EA, Stubberfield CR, Turner PR 2,3-Dihydro-1,3-dioxo-1H-isoindole-5-carboxylic acid derivatives: a novel class of small molecule heparanase inhibitors. Bioorg Med Chem Lett 2004, 14:3269-3273.
-
(2004)
Bioorg Med Chem Lett
, vol.14
, pp. 3269-3273
-
-
Courtney, S.M.1
Hay, P.A.2
Buck, R.T.3
Colville, C.S.4
Porter, D.W.5
Scopes, D.I.6
Pollard, F.C.7
Page, M.J.8
Bennett, J.M.9
Hircock, M.L.10
McKenzie, E.A.11
Stubberfield, C.R.12
Turner, P.R.13
-
10
-
-
4143140258
-
Structure-based design of a selective heparanase inhibitor as an antimetastatic agent
-
Ishida K, Hirai G, Murakami K, Teruya T, Simizu S, Sodeoka M, Osada H Structure-based design of a selective heparanase inhibitor as an antimetastatic agent. Mol Cancer Ther 2004, 3:1069-1077.
-
(2004)
Mol Cancer Ther
, vol.3
, pp. 1069-1077
-
-
Ishida, K.1
Hirai, G.2
Murakami, K.3
Teruya, T.4
Simizu, S.5
Sodeoka, M.6
Osada, H.7
-
11
-
-
27944476660
-
N-(4-{[4-(1H-Benzoimidazol-2-yl)-arylamino]-methyl}-phenyl)-benzamide derivatives as small molecule heparanase inhibitors
-
Xu YJ, Miao HQ, Pan W, Navarro EC, Tonra JR, Mitelman S, Camara MM, Deevi DS, Kiselyov AS, Kussie P, Wong WC, Liu H N-(4-{[4-(1H-Benzoimidazol-2-yl)-arylamino]-methyl}-phenyl)-benzamide derivatives as small molecule heparanase inhibitors. Bioorg Med Chem Lett 2006, 16:404-408.
-
(2006)
Bioorg Med Chem Lett
, vol.16
, pp. 404-408
-
-
Xu, Y.J.1
Miao, H.Q.2
Pan, W.3
Navarro, E.C.4
Tonra, J.R.5
Mitelman, S.6
Camara, M.M.7
Deevi, D.S.8
Kiselyov, A.S.9
Kussie, P.10
Wong, W.C.11
Liu, H.12
-
12
-
-
33749347624
-
A phase I biological and pharmacologic study of the heparanase inhibitor PI-88 in patients with advanced solid tumors
-
Basche M, Gustafson DL, Holden SN, O'Bryant CL, Gore L, Witta S, Schultz MK, Morrow M, Levin A, Creese BR, Kangas M, Roberts K, Nguyen T, Davis K, Addison RS, Moore JC, Eckhardt SG A phase I biological and pharmacologic study of the heparanase inhibitor PI-88 in patients with advanced solid tumors. Clin Cancer Res 2006, 12:5471-5480.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 5471-5480
-
-
Basche, M.1
Gustafson, D.L.2
Holden, S.N.3
O'Bryant, C.L.4
Gore, L.5
Witta, S.6
Schultz, M.K.7
Morrow, M.8
Levin, A.9
Creese, B.R.10
Kangas, M.11
Roberts, K.12
Nguyen, T.13
Davis, K.14
Addison, R.S.15
Moore, J.C.16
Eckhardt, S.G.17
-
13
-
-
84984569951
-
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosage
-
Liu CJ, Lee PH, Lin DY, Wu CC, Jeng LB, Lin PW, Mok KT, Lee WC, Yeh HZ, Ho MC, Yang SS, Lee CC, Yu MC, Hu RH, Peng CY, Lai KL, Chang SS, Chen PJ Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosage. J Hepatol 2009, 50:958-968.
-
(2009)
J Hepatol
, vol.50
, pp. 958-968
-
-
Liu, C.J.1
Lee, P.H.2
Lin, D.Y.3
Wu, C.C.4
Jeng, L.B.5
Lin, P.W.6
Mok, K.T.7
Lee, W.C.8
Yeh, H.Z.9
Ho, M.C.10
Yang, S.S.11
Lee, C.C.12
Yu, M.C.13
Hu, R.H.14
Peng, C.Y.15
Lai, K.L.16
Chang, S.S.17
Chen, P.J.18
-
14
-
-
79959266354
-
M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasis
-
Zhou H, Roy S, Cochran E, Zouaoui R, Chu CL, Duffner J, Zhao G, Smith S, Galcheva-Gargova Z, Karlgren J, Dussault N, Kwan RY, Moy E, Barnes M, Long A, Honan C, Qi YW, Shriver Z, Ganguly T, Schultes B, Venkataraman G, Kishimoto TK M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasis. PLoS One 2011, 6:e21106.
-
(2011)
PLoS One
, vol.6
-
-
Zhou, H.1
Roy, S.2
Cochran, E.3
Zouaoui, R.4
Chu, C.L.5
Duffner, J.6
Zhao, G.7
Smith, S.8
Galcheva-Gargova, Z.9
Karlgren, J.10
Dussault, N.11
Kwan, R.Y.12
Moy, E.13
Barnes, M.14
Long, A.15
Honan, C.16
Qi, Y.W.17
Shriver, Z.18
Ganguly, T.19
Schultes, B.20
Venkataraman, G.21
Kishimoto, T.K.22
more..
-
15
-
-
79952731895
-
SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis
-
Ritchie JP, Ramani VC, Ren Y, Naggi A, Torri G, Casu B, Penco S, Pisano C, Carminati P, Tortoreto M, Zunino F, Vlodavsky I, Sanderson RD, Yang Y SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis. Clin Cancer Res 2011, 17:1382-1393.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 1382-1393
-
-
Ritchie, J.P.1
Ramani, V.C.2
Ren, Y.3
Naggi, A.4
Torri, G.5
Casu, B.6
Penco, S.7
Pisano, C.8
Carminati, P.9
Tortoreto, M.10
Zunino, F.11
Vlodavsky, I.12
Sanderson, R.D.13
Yang, Y.14
-
16
-
-
77952239575
-
The PG500 series: novel heparan sulfate mimetics as potent angiogenesis and heparanase inhibitors for cancer therapy
-
Dredge K, Hammond E, Davis K, Li CP, Liu L, Johnstone K, Handley P, Wimmer N, Gonda TJ, Gautam A, Ferro V, Bytheway I The PG500 series: novel heparan sulfate mimetics as potent angiogenesis and heparanase inhibitors for cancer therapy. Invest New Drugs 2010, 28:276-283.
-
(2010)
Invest New Drugs
, vol.28
, pp. 276-283
-
-
Dredge, K.1
Hammond, E.2
Davis, K.3
Li, C.P.4
Liu, L.5
Johnstone, K.6
Handley, P.7
Wimmer, N.8
Gonda, T.J.9
Gautam, A.10
Ferro, V.11
Bytheway, I.12
-
17
-
-
79951676056
-
PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models
-
Dredge K, Hammond E, Handley P, Gonda TJ, Smith MT, Vincent C, Brandt R, Ferro V, Bytheway I PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models. Br J Cancer 2011, 104:635-642.
-
(2011)
Br J Cancer
, vol.104
, pp. 635-642
-
-
Dredge, K.1
Hammond, E.2
Handley, P.3
Gonda, T.J.4
Smith, M.T.5
Vincent, C.6
Brandt, R.7
Ferro, V.8
Bytheway, I.9
-
18
-
-
84871602830
-
PG545, a heparan sulfate mimetic, reduces heparanase expression in vivo, blocks spontaneous metastases and enhances overall survival in the 4T1 breast carcinoma model
-
Hammond E, Brandt R, Dredge K PG545, a heparan sulfate mimetic, reduces heparanase expression in vivo, blocks spontaneous metastases and enhances overall survival in the 4T1 breast carcinoma model. PLoS One 2012, 7:e52175.
-
(2012)
PLoS One
, vol.7
-
-
Hammond, E.1
Brandt, R.2
Dredge, K.3
-
19
-
-
70449670332
-
Development of a colorimetric assay for heparanase activity suitable for kinetic analysis and inhibitor screening
-
Hammond E, Li CP, Ferro V Development of a colorimetric assay for heparanase activity suitable for kinetic analysis and inhibitor screening. Anal Biochem 2010, 396:112-116.
-
(2010)
Anal Biochem
, vol.396
, pp. 112-116
-
-
Hammond, E.1
Li, C.P.2
Ferro, V.3
-
20
-
-
84860271832
-
Discovery of PG545: a highly potent and simultaneous inhibitor of angiogenesis, tumor growth, and metastasis
-
Ferro V, Liu L, Johnstone KD, Wimmer N, Karoli T, Handley P, Rowley J, Dredge K, Li CP, Hammond E, Davis K, Sarimaa L, Harenberg J, Bytheway I Discovery of PG545: a highly potent and simultaneous inhibitor of angiogenesis, tumor growth, and metastasis. J Med Chem 2012, 55:3804-3813.
-
(2012)
J Med Chem
, vol.55
, pp. 3804-3813
-
-
Ferro, V.1
Liu, L.2
Johnstone, K.D.3
Wimmer, N.4
Karoli, T.5
Handley, P.6
Rowley, J.7
Dredge, K.8
Li, C.P.9
Hammond, E.10
Davis, K.11
Sarimaa, L.12
Harenberg, J.13
Bytheway, I.14
-
21
-
-
84882985796
-
-
Wimmer N and Hammond ET (2009) Novel sulfated oligosaccharide derivatives. WO/2009/049370
-
Ferro V, Karoli T, Liu L, Handley PN, Johnstone KD, Wimmer N and Hammond ET (2009) Novel sulfated oligosaccharide derivatives. WO/2009/049370.
-
-
-
Ferro, V.1
Karoli, T.2
Liu, L.3
Handley, P.N.4
Johnstone, K.D.5
-
22
-
-
0042366191
-
Biochemical characterization of the active heterodimer form of human heparanase (Hpa1) protein expressed in insect cells
-
McKenzie E, Young K, Hircock M, Bennett J, Bhaman M, Felix R, Turner P, Stamps A, McMillan D, Saville G, Ng S, Mason S, Snell D, Schofield D, Gong H, Townsend R, Gallagher J, Page M, Parekh R, Stubberfield C Biochemical characterization of the active heterodimer form of human heparanase (Hpa1) protein expressed in insect cells. Biochem J 2003, 373:423-435.
-
(2003)
Biochem J
, vol.373
, pp. 423-435
-
-
McKenzie, E.1
Young, K.2
Hircock, M.3
Bennett, J.4
Bhaman, M.5
Felix, R.6
Turner, P.7
Stamps, A.8
McMillan, D.9
Saville, G.10
Ng, S.11
Mason, S.12
Snell, D.13
Schofield, D.14
Gong, H.15
Townsend, R.16
Gallagher, J.17
Page, M.18
Parekh, R.19
Stubberfield, C.20
more..
-
23
-
-
29744433264
-
Synthesis, biological activity, and preliminary pharmacokinetic evaluation of analogues of a phosphosulfomannan angiogenesis inhibitor (PI-88)
-
Karoli T, Liu L, Fairweather JK, Hammond E, Li CP, Cochran S, Bergefall K, Trybala E, Addison RS, Ferro V Synthesis, biological activity, and preliminary pharmacokinetic evaluation of analogues of a phosphosulfomannan angiogenesis inhibitor (PI-88). J Med Chem 2005, 48:8229-8236.
-
(2005)
J Med Chem
, vol.48
, pp. 8229-8236
-
-
Karoli, T.1
Liu, L.2
Fairweather, J.K.3
Hammond, E.4
Li, C.P.5
Cochran, S.6
Bergefall, K.7
Trybala, E.8
Addison, R.S.9
Ferro, V.10
-
24
-
-
0033565247
-
Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity
-
Parish CR, Freeman C, Brown KJ, Francis DJ, Cowden WB Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity. Cancer Res 1999, 59:3433-3441.
-
(1999)
Cancer Res
, vol.59
, pp. 3433-3441
-
-
Parish, C.R.1
Freeman, C.2
Brown, K.J.3
Francis, D.J.4
Cowden, W.B.5
-
26
-
-
77950496679
-
Inhibition kinetics of catabolic dehydrogenases by elevated moieties of ATP and ADP - implication for a new regulation mechanism in Lactococcus lactis
-
Cao R, Zeidan AA, Rådström P, van Niel EW Inhibition kinetics of catabolic dehydrogenases by elevated moieties of ATP and ADP - implication for a new regulation mechanism in Lactococcus lactis. FEBS J 2010, 277:1843-1852.
-
(2010)
FEBS J
, vol.277
, pp. 1843-1852
-
-
Cao, R.1
Zeidan, A.A.2
Rådström, P.3
van Niel, E.W.4
-
27
-
-
33750045454
-
Structure modeling, ligand binding, and binding affinity calculation (LR-MM-PBSA) of human heparanase for inhibition and drug design
-
Zhou Z, Bates M, Madura JD Structure modeling, ligand binding, and binding affinity calculation (LR-MM-PBSA) of human heparanase for inhibition and drug design. Proteins 2006, 65:580-592.
-
(2006)
Proteins
, vol.65
, pp. 580-592
-
-
Zhou, Z.1
Bates, M.2
Madura, J.D.3
-
28
-
-
80055046592
-
Molecular model of human heparanase with proposed binding mode of a heparan sulfate oligosaccharide and catalytic amino acids
-
Sapay N, Cabannes E, Petitou M, Imberty A Molecular model of human heparanase with proposed binding mode of a heparan sulfate oligosaccharide and catalytic amino acids. Biopolymers 2012, 97:21-34.
-
(2012)
Biopolymers
, vol.97
, pp. 21-34
-
-
Sapay, N.1
Cabannes, E.2
Petitou, M.3
Imberty, A.4
-
29
-
-
38849208571
-
Synthesis and heparanase inhibitory activity of sulfated mannooligosaccharides related to the antiangiogenic agent PI-88
-
Fairweather JK, Hammond E, Johnstone KD, Ferro V Synthesis and heparanase inhibitory activity of sulfated mannooligosaccharides related to the antiangiogenic agent PI-88. Bioorg Med Chem 2008, 16:699-709.
-
(2008)
Bioorg Med Chem
, vol.16
, pp. 699-709
-
-
Fairweather, J.K.1
Hammond, E.2
Johnstone, K.D.3
Ferro, V.4
|